Gynecologic aspects of malignancies following immunosuppressive or cytotoxic therapy.
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation; D007938:Leukemia / Q000139:chemically induced; D008223:Lymphoma / Q000139:chemically induced; D009369:Neoplasms / Q000139:chemically induced*; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents